1. In this study mast cells were found to comprise 2.1% of total cells recovered by enzymatic digestion of human lung tissue.
INTRODUCTION
Pulmonary mast cells may play an important role in the pathogenesis of asthma [ 11. In the respiratory tract, mast cells are located in the submucosa of the conducting airways towards the periphery [ l , 21. The airway mast cells are predominantly located in loose and dense connective tissue [3] , but some are also found in the epithelium directly adjacent to the bronchial lumen and in the alveoli [4, 5] .
Based on different staining characteristics, atypical mast cells were observed in rat intestinal mucosa [6] . In consecutive studies subpopulations of rat mast cells could be identified by their fixation and staining properties. These cells were called mucosal (MMC) and connective tissue (CTMC) mast cells [7, 81. Both these cell-types preserve well in Carnoy's fluid, but MMC failed to stain after fixation in formol-saline [9] . On the basis of this capacity Mh4C were called formalin-sensitive (FS), whereas CTMC were called formalin-insensitive (FI), mast cells. The blue colour of the granules after Alcian Blue-Safranin 0 staining was characteristic for rodent MMC, but could also be seen in young CTMC [lo] . In contrast to MMC, CTMC contained intensely red metachromatically stained granules. Mast cells were considered Safranin-positive when more than 75% of the granules stained red. MMC and CTMC also differed in size and nuclear morphology [l 11. In comparison with CTMC, MMC contained less histamine, contained no heparin and generated predominantly leukotriene C4 (LTC,) and leukotriene D, instead of prostaglandin D, ( E D , ) [ 1 1-1 31.
In man, mast cell heterogeneity was studied by comparing the distribution and abundance of mast cells in the intestine and respiratory tract after fixation with Mota's basic lead acetate or neutral formalin. Two histochemically distinct subpopulations were demonstrated and their distribution and abundance pattern varied from one anatomical site to another [9, 14, 151. In support of this observation there is recent evidence for the existence of two types of mast cells in human intestine and skin which have distinct neutral protease compositions [ 161. Based on formalin-sensitivity, mast cell heterogeneity was reported for human nasal mast cells [17] . Hitherto, pulmonary mast cells were found to be heterogeneous with respect to size and granule content only [18, 191. Mast cells dispersed from human skin, lung, adenoids, tonsils and colon by the same enzymatic technique responded differently to immunological and nonimmunological challenge [20] .
In this paper, we extend the evidence for the existence of mast cell subtypes in normal human lung tissue.
MATERIALS AND METHODS

Materials
Calcium-free Tyrode's buffer (TGMD buffer) was used and contained 137 mmol/l NaCI, 2.7 mmol/l KCl, 0.4 mmol/l sodium phosphate buffer, 1.2 mmol/l MgCI2, 5.6 mmol/l glucose, 60 mg of deoxyribonuclease type I (from bovine pancreas; EC 3.1.2 1.1 ; Boehringer, Mannheim, West Germany)/l, 1% (w/v) gelatin, 1000 units of penicillin (Sigma Chemical Co., St Louis, MO, U.S.A.)/I and 1 mg of streptomycin (Sigma)/l. The pH of the solution was adjusted to 7.4 at room temperature (20°C). The osmolality of the solution was 290 mosmol/kg, as measured by freezing point depression.
The isotonic shock solution contained 155 mmol/l NH,CI, 10 mmol/l KHCO,, 0.1 mmol/l ethylenediaminetetra-acetic acid (disodium salt) and 10 mg of Phenol Red/l. The pH of the solution was adjusted to 7.4 at OOC, because the solution was used at this temperature. The osmolality of the solution was 290 mosmol/kg determined as above.
Mast cell medium used during the mediator release experiments contained 150 mmol/l NaCl, 3.7 mmol/l KCI, 3.5 mmol/l KH2P0,, 3.9 mmol/l Na2HP0,.2H20, 0.9 mmol/l CaC1,.2H20, 5.6 mrnol/l glucose and 10% (w/v) bovine serum albumin (Sigma).
The substrate solution, used for chloroacetateesterase staining, was made from three drops of pararosanilin solution (40 mg/ml; Merck, Darmstadt, West Germany) in 2 mol/l HCl and three drops of NaNO, solution (40 mg/ml). Both solutions were mixed and after 60 s were diluted in 90 ml of Michaelis buffer (0.22 mol/l sodium acetate, 0.14 mol/l sodium barbiturate, pH 6.8).
The pH was adjusted to 6.3.3-Hydroxy-2-naphthoic acid 2-methylanilide-chloroacetate (30 mg; Sigma) was dissolved in 3 ml of N,N-dimethylformamide (Merck).
The solutions were mixed, shaken vigorously and filtered. The clear red filtrate was used.
Other materials used were: RPMI-1640 and fetal calf serum (Gibco Ltd, Paisley, U.K.); pronase type XXI (from 
Enzymatic digestion
Human lung tissue was obtained at thoracotomy, mainly performed for the resection of bronchial carcinomas. Macroscopically normal lung tissue was dissected free of major blood vessels. Subsequently, the tissue was fragmented with scissors and suspended in RPMI-1640 with 10% (v/v) heat-inactivated (30 min, 56°C) fetal calf serum. The lung fragments were washed to remove blood cells and were digested by one exposure to pronase (2 mg/ml) and chymopapain (0.5 mg/ml) and three consecutive exposures to collagenase (1 mg/ml) and elastase (10 units/ml) (30 min each, at 37°C). Enzymes were dissolved in TGMD buffer. After each treatment the dispersed cells were filtered through aseptic gauze and collected. Erythrocytes were removed by an isotonic shock procedure (5 min at OOC) [2 11.
Counterflow elutriation
The enzymatically dispersed cells were separated into different fractions by centrifugal elutriation. A type JE-6 elutriation rotor driven by a 5-2 1B centrifuge (Beckman Instruments, Palo Alto, CA, U.S.A.) was used. The rotation speed was measured by a stroboscope, which allowed accurate speed control during the procedure. After washing the system with 500 ml of TGMD buffer, the cells were loaded at a buffer flow of 20 ml/min and at a rotation speed of 3000 rev./min. Subsequently, the cells were separated by decreasing the rotation speed to 2700, 2 100, 1800 and 1200 rev./min. After each adjustment in rotation speed, fractions of 150 ml were collected. After centrifugation, the cells obtained in the different fractions were suspended in 1 ml of TGMD and mast cell contents were determined.
Gradient centrifugation
A discontinuous isotonic Percoll gradient ranging from 1.050 to 1.1 00 g/ml was prepared by layering in a tube 2 ml each of the densities 1.050, 1.060, 1.072, 1.082 and 1.100 g/ml, which were obtained by diluting a stock solution of Percoll (1.100 g/ml) with ten times concentrated phosphate-buffered saline (PBS). The osmolality of the different krcoll densities was 295 mosmol/kg. The lung cell fraction obtained at a rotation speed of 2 100 rev./min during elutriation was layered on to the Percoll gradient and centrifuged (400 g, 20 min, 20°C). Cells were collected from the different bands and were washed twice to remove the Percoll. A band between the densities 'a'
and 'b, with %'>'a', was designated band <'b'. Each band was analysed for mast cell content.
Morphological characterization
Cytocentrifuge smears of all cell fractions were prepared at each step during the isolation procedure. Differential cell counts were performed by May-Griinwald/Giemsa staining. Differential mast cell counts were established on duplicate smears of the cell fractions. These smears were fixed for 30 rnin in either The residual percentage is that of the FS-mast cells.
Differentiation between mast cells and basophils was made by electron micrographs and staining for chloroacetate-esterase.
Cytocentrifuge smears were fixed in formalin (10% (v/ v) formalin in PBS) for 10 min. The fixed smears were incubated in the substrate solution (30 min, 20°C). The slides were then rinsed with running tap water and counterstained with Harris' haematoxylin for 2 min. In contrast to basophils, mast cells were positive for chloroacetate-esterase.
To compare the number of IgE-bearing cells with the number of Alcian Blue-positive cells in each fraction, a procedure employing staining with FITC-labelled antiIgE was performed. The number of anti-lgE-positive cells was examined by fluorescence microscopy.
For electron microscopy, cells in suspension were fixed for 2 h at room temperature in a solution of 2% glutaraldehyde in 0.1 mol/l cacodylate buffer (final concentration) at pH 7.4. The cells were pelleted at 10000 gfor 5 min. The pellet was postfixed, and block stained. Thin sections were stained in uranyl acetate and lead citrate and then examined using an electron microscope.
Mediator release
The FS-mast cell and the FI-mast cell predominant fractions were studied for mediator release after challenge with different secretagogues. Mast cells (1.5 x lo4) were suspended in 1 ml of mast cell medium and challenged with goat anti-human IgE (dilution 1 :lo), dl-propranolol dihydrochloride (0.34 ymol/ml), or compound 48/80 (1 yg/ml) for 5 rnin at 37°C. The mast cells were also challenged with opsonized zymosan (5 mg/ml) for 20 min at 37°C [23] . Mediator release was stopped by centrifugation at 250 g for 3 rnin at 4°C. The supernatant was removed and assayed for histamine, LTC, and PGD, content.
Histamine content was assayed by a double (3H, 14C) isotope assay [24] . Cellular histamine content was assayed after three rounds of freezing and thawing of the cells in liquid nitrogen.
In the calculation of results, all values were corrected for spontaneous release of mediators in the absence of a challenge. Histamine release was expressed as a percentage of the total cellular histamine content of duplicate samples. Examination for histamine loss was performed on each fraction obtained at the different isolation steps.
LTC, and PGDz were detected by a 3H radioimmunoassay [25] , and their formation was expressed as ng/106 mast cells.
Viability
Cell viability was monitored at each step during the isolation procedure by Trypan Blue dye (0.02%, w/v) exclusion. Viability of the nucleated lung cells exceeded 95% at each isolation step.
Statistical analysis
Results are expressed as means (SEM), with n denoting the number of experiments performed. The two-tailed Student's t-test was used to determine the statistical difference between the mean values of two sets of data. A P value of < 0.05 was considered statistically significant.
Linear regression was performed by the least squares method.
RESULTS
Enzymatic digestion
Enzymatic digestion of human lung tissue yielded 15.0 x loh (SEM 1. 
Counterflow elutriation
The suspension loaded on to the elutriator consisted of nucleated cells (range 64.5-195.0~ lo6) with a mean mast cell purity of 2.1% (SEM 0.4, n = 12). The cellular composition and the cell yield of the different elutriation fractions are given in Table 1 . Mast cell numbers and their recoveries in the elutriation fractions are summarized in Table 2 . The fraction obtained at 3000 rev./min contained virtually no mast cells. When compared with fixation in formalin, fixation in Carnoy's fluid always resulted in a greater number of Alcian Blue-positive mast cells. It appeared that this difference was significant in the elutriation fractions 3000, 2700 and 2100 (P<O.Ol, WO.01 and P< 0.05, respectively). After elutriation the recoveries of the mast cell subtypes, as determined by Alcian Blue positivity of the fractions, were 75% (range 30-1 1 So/,) for FS-mast cells and 68% (range 44-103%) for F1-mast cells ( Table 2 ). The total recovery of all cells after the elutriation procedure was 61% (SEM 4, n = 12, range 5348%).
Gradient centrifugation
The suspension of cells, obtained by elutriation at 2 100 rev./min, loaded on to the Percoll gradient contained, among other cells, 1.2X lo6 (SEM 0.5, n== 12, range  0.2-3.3X lo6) FS-mast cells and 1.9x los (SEM 0.3, n = 12, range 0.9-2.7 x lo5) FI-mast cells. The cellular composition and the cell yield of the various bands obtained after centrifugation are given in Table 3 . The mast cell numbers and their recoveries in these bands are given in Table 4 . Table 4 illustrates the significant differences in distribution pattern of Carnoy-fied and formalin-fixed mast cells over the Percoll gradient fractions. The FS-mast cells were recovered at higher densities than the FI-mast cells. After gradient centrifugation the recoveries of the mast cell subtypes were 81% (range 60-102%) for FS-mast cells and 89% (range 54-1 12%) for FI-mast cells ( Table  4 ). The total recovery of all cells after the gradient centrifugation procedure was 92% (SEM 9, n -12; range 70-125%). Mast cell purities and recoveries at the three stages are listed in Table 5 .
Morphological characterization
By May-Griinwald/Giemsa staining differentiation between mast cells and basophils is only possible due to their difference in nucleus morphology. Therefore staining with chloroacetate-esterase, which only stains mast cells, was performed to exclude the presence of basophils. Cells positive for chloroacetate-esterase in all Percoll fractions equalled the number of Alcian Blue-positive cells.
Table 1. Differential cell count and cell yield for each fraction obtained after centrifugal elutriation
Results are means k SEM ( n = 12). Table 5 . Summary of mast cell purities and recoveries at each purification stage
Results are means f SEM ( n = 12).
Step Purity (70) Recovery ("/o)
FS-cells FI-cells FS-cells FI-cells
which most resembles the blood basophil in its functional characteristics, has an obvious mast cell morphology. An enriched population of basophils from peripheral blood was also stained for the presence of chloroacetate-esterase, but these cells were negative. To confirm that basophils were not present, electron micrographs were made of both FS-cell-and FI-cellcontaining suspensions. Electron micrographs of FI-and FS-mast cells are shown in Fig. 1 . Both micrographs show characteristics typical of mast cells, although both cells turned out to be different in granule content. The FS-cell,
Histamine levels
Linear regression analysis revealed a significant correlation between histamine levels and mast cell counts per ml of the dispersed lung cell suspension (Fig. 2) . To obtain an indication of histamine content of either subtype, histamine in different fractions was assayed. possibility of intracellular histamine being lost through enzymatic dispersal of cells, washing or activation was a matter of concern. However, the supernatant of each fraction obtained at the different isolation steps was examined for histamine, but all were negative.
Functional characterization
In all functional studies with both mast cell subtypes, 1.5 X lo4 mast cells were used per incubation. Before anti-lgE challenge studies, the number of cells positive for FITC-labelled anti-IgE were shown to equal the number of Alcian Blue-positive cells in the aliquots to be challenged. This indicated the absence of IgE-receptorbearing cells other than mast cells which might influence the reaction. After challenge of preparations containing predominantly FI-or FS-mast cells with anti-human IgE, histamine release was observed. A different release pattern between subtypes was observed (P<0.05, n=10). In preparations containing 1% (SEM 1, n = 10) FI-mast cells maximal histamine release amounted to 59% (SEM 3, n = 10) of total histamine content after challenge with anti-human IgE, whereas in preparations containing 2 1% (SEM 1, n = 10) FS-mast cells it was 33% (SEM 5, n = 10) ( Table 6 ). In the preparations containing 21% FS-mast cells the release of LTC, upon challenge with anti-human IgE was 4.6 ng (SEM 1.1, n = 10) per lo6 mast cells. No release of LTC, was observed in the preparations containing predominantly FI-mast cells. After challenge with anti-IgE, release of 386 ng of E D z (SEM 7, n = 3) per lo6 mast cells was observed for the preparation containing 1% FI-mast cells. No detectable PGD, release was found for the FS-cell-containing preparations (Table 6) .
After challenge with opsonized zymosan, a significant maximal histamine release of 72% (SEM 5, n = 4 ) was shown only for the fraction containing 2 1% mast cells of which were 97% FS-type (Table 6 ). Challenge with propranolol or compound 48/80 resulted in limited maximal histamine release (Table 6 ).
The spontaneous release of histamine in these experiments was always less than 7%.
DISCUSSION
Earlier reports have described the existence of mast cell subtypes in rodents, i.e. MMC and CTMC [7, 8, 141 . The subtypes were shown to differ functionally in rodents [ 12, 26) . In this paper we describe the presence and separation of two types of human lung mast cells. These mast cell [ 18, 191 . A similar mast cell heterogeneity based on formalinsensitivity has been described for mast cells present in the nose [ 171. By using this histochemical difference we have been able to separate these mast cell subtypes by elutriation centrifugation and krcoll density gradient centrifugation. The elutriation fraction obtained at 2100 rev./min was chosen for further separation, because only this fraction gave sufficient yields which after further separation offered the possibility of studying functional characteristics such as mediator release. After krcoll density gradient centrifugation it became clear that the FI-mast cells did have a significant lower density than the FS-mast cells. This allowed separation of both mast cell subtypes. Although separated from each other, the final purity of either of the separated mast cell subtypes did not exceed 40% (see Table 5 ). This separation was sufficient for performing functional assays with anti-human IgE, since the other cell types present (see Table 3 ) did not bear IgE on their surface and histamine was not present in the contaminating cells.
To exclude the presence of basophils some discriminating studies were performed. The presence of chloroacetate-esterase in the isolated cells, which is not present in peripheral blood basophils. and the morphology of these cells seen on the electron micrographs confirm that we were dealing with mast cells. The electron micrograph of the FS-cell, which in its functional behaviour resembles a blood basophil, showed a characteristic mast cell morphology.
Our results suggest that the histamine content of FSand FI-mast cell subpopulations differs significantly. The FS-mast cells contained on average 1.34 pg of histamine per cell and the FI-mast cells 4.1 7 pg per cell. Unweighted linear regression analysis of histamine content and human pulmonary mast cell numbers revealed coefficients of r = 0.7 1 and r = 0.43 for FS-and FI-mast cells ( P < 0.00 1 and P < 0.05), respectively. These correlations between cell-associated histamine and mast cell counts were better for both FS-and F1-mast cells than those reported earlier [27, 281. Hitherto, many reports have dealt with histamine contents of human pulmonary mast cells. In general, values were found between 1 and 11 pg per cell [9, 181. Schulman el al. [18] reported the greatest range of histamine content of mast cells: 2.7 pg in small mast cells to The observed difference in functional behaviour between FS-and FI-mast cell subtypes may be compared with some characteristics of rodent MMC and CTMC and mast cell subtypes in human nose. The percentage of histamine released from both human pulmonary subtypes in response to anti-IgE was dose dependent, and was higher in F1-mast cells. In the human nose a higher percentage of histamine was found to be released by FS-mast cells [ 171. In addition, mast cells from different tissue sites were seen to differ in the extent of histamine secretion in response to this stimulus, but these mast cells were not differentiated with respect to subtype [20] . In rodents no differences in histamine release were observed between mast cell subtypes [12] . The lack of response to challenge with compound 48/80 was also observed for the mast cell subpopulations in human nose and for the MMC in rodents [12, 171 . Human skin mast cells responded to challenge with basic non-immunological stimuli, i.e. compound 48/80 [20] . LTC, release after stimulation of FSmast cells with anti-lgE is in accordance with earlier reports [4, 301. PGD, release was observed in chopped lung tissue of rodents and was related to mast cells [4] . So far, in man, no relation to mast cell subtypes has been described. However, we have observed that PGD, release from human pulmonary mast cells is a characteristic of FI-mast cells and comparable with the rodent CTMC.
Because neutrophils are present in FS-mast-cell-containing suspensions, histamine release observed after challenge with opsonized zymosan may be ascribed to neutrophil-derived histamine-releasing activity generated by neutrophils upon challenge with the latter stimulant
In conclusion, a number of biochemical and functional characteristics have been reported for mast cells from human lung tissue, which extend the evidence for the 1311.
existence of heterogeneity within this cell population. The significance of this mast cell heterogeneity for the pathogenesis of certain lung diseases is unclear at the moment, but is the subject of current investigations.
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